INS and pancreatitis: Notably, no disproportionate reporting of “pancreatitis” and “biliary colic” was observed vs. SGLT-2i, while a greater risk was described vs. insulin (ROR 1.58, 95% CI 1.37–1.82, for “pancreatitis”, and ROR 2.40, 95% CI 1.16–4.94, for “biliary colic”) (Fig. 4C, D).